These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23280546)

  • 1. Spatially matched in vivo and ex vivo MR metabolic profiles of prostate cancer -- investigation of a correlation with Gleason score.
    Selnaes KM; Gribbestad IS; Bertilsson H; Wright A; Angelsen A; Heerschap A; Tessem MB
    NMR Biomed; 2013 May; 26(5):600-6. PubMed ID: 23280546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
    García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM
    Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spermine and citrate as metabolic biomarkers for assessing prostate cancer aggressiveness.
    Giskeødegård GF; Bertilsson H; Selnæs KM; Wright AJ; Bathen TF; Viset T; Halgunset J; Angelsen A; Gribbestad IS; Tessem MB
    PLoS One; 2013; 8(4):e62375. PubMed ID: 23626811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
    Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
    Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
    Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
    Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy.
    Braadland PR; Giskeødegård G; Sandsmark E; Bertilsson H; Euceda LR; Hansen AF; Guldvik IJ; Selnæs KM; Grytli HH; Katz B; Svindland A; Bathen TF; Eri LM; Nygård S; Berge V; Taskén KA; Tessem MB
    Br J Cancer; 2017 Nov; 117(11):1656-1664. PubMed ID: 28972967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience.
    Hom JJ; Coakley FV; Simko JP; Lu Y; Qayyum A; Westphalen AC; Schmitt LD; Carroll PR; Kurhanewicz J
    Radiology; 2007 Feb; 242(2):483-9. PubMed ID: 17179396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton MR spectroscopy of the prostate.
    Mueller-Lisse UG; Scherr MK
    Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
    Zakian KL; Sircar K; Hricak H; Chen HN; Shukla-Dave A; Eberhardt S; Muruganandham M; Ebora L; Kattan MW; Reuter VE; Scardino PT; Koutcher JA
    Radiology; 2005 Mar; 234(3):804-14. PubMed ID: 15734935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification.
    Bellomo G; Marcocci F; Bianchini D; Mezzenga E; D'Errico V; Menghi E; Zannoli R; Sarnelli A
    PLoS One; 2016; 11(11):e0165730. PubMed ID: 27832096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral zone prostate cancer. Pre-treatment evaluation with MR and 3D ¹H MR spectroscopic imaging: correlation with pathologic findings.
    Giusti S; Caramella D; Fruzzetti E; Lazzereschi M; Tognetti A; Bartolozzi C
    Abdom Imaging; 2010 Dec; 35(6):757-63. PubMed ID: 19756851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution.
    Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ
    Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
    Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
    Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase and frequency alignment protocol for 1H MRSI data of the prostate.
    Wright AJ; Buydens LM; Heerschap A
    NMR Biomed; 2012 May; 25(5):755-65. PubMed ID: 21953616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in gene transcription underlying the aberrant citrate and choline metabolism in human prostate cancer samples.
    Bertilsson H; Tessem MB; Flatberg A; Viset T; Gribbestad I; Angelsen A; Halgunset J
    Clin Cancer Res; 2012 Jun; 18(12):3261-9. PubMed ID: 22510345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H-MRSI of prostate cancer: the relationship between metabolite ratio and tumor proliferation.
    Wang XZ; Wang B; Gao ZQ; Liu JG; Liu ZQ; Niu QL; Sun ZK; Yuan YX
    Eur J Radiol; 2010 Feb; 73(2):345-51. PubMed ID: 19070978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of endorectal 2D JPRESS findings with pathological Gleason scores in prostate cancer patients.
    Nagarajan R; Gomez AM; Raman SS; Margolis DJ; McClure T; Thomas MA
    NMR Biomed; 2010 Apr; 23(3):257-61. PubMed ID: 19795373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
    Valentini AL; Gui B; D'Agostino GR; Mattiucci G; Clementi V; Di Molfetta IV; Bonomo P; Mantini G
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):719-24. PubMed ID: 22436789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness.
    Iordanescu G; Brendler C; Crawford SE; Wyrwicz AM; Venkatasubramanian PN; Doll JA
    J Magn Reson Imaging; 2015 Sep; 42(3):651-7. PubMed ID: 25522916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer.
    Hasumi M; Suzuki K; Oya N; Ito K; Kurokawa K; Fukabori Y; Yamanaka H
    Anticancer Res; 2002; 22(2B):1205-8. PubMed ID: 12168926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.